SIBO Breath Test: How to Interpret Your Results

What the SIBO Breath Test Actually Measures

The test gives you a time-series graph of gas concentrations in parts per million (ppm). You are not measuring bacteria directly. You are measuring the gases those bacteria exhale as byproducts of fermenting carbohydrates in your small intestine.

Two gases matter most:

• Hydrogen (H2): Produced by many bacterial species when they ferment undigested sugars. A fast, early rise points to bacterial activity in the small bowel rather than the colon.
• Methane (CH4): Produced primarily by a single archaea species called Methanobrevibacter smithii. High methane correlates strongly with constipation-predominant symptoms.

A third gas, hydrogen sulfide (H2S), is now measurable with newer tri-gas devices. Research published in Digestive Diseases and Sciences suggests H2S-dominant overgrowth may explain many patients who test negative on standard two-gas panels yet still have classic SIBO symptoms, a phenomenon sometimes called "flat-line" SIBO.

The Two Substrates: Lactulose vs. Glucose

The sugar solution you drink before the test is not a detail. It determines what the test can detect.

| Substrate | What it detects | False-positive risk | False-negative risk | |-----------|----------------|--------------------|--------------------| | Lactulose | Bacteria anywhere in small intestine | Higher (colonic fermentation can mimic early rise) | Lower | | Glucose | Bacteria in proximal small intestine only | Lower | Higher (distal SIBO missed) |

The North American Consensus on breath testing published in American Journal of Gastroenterology in 2017 recommends glucose as the preferred substrate for SIBO detection given its lower false-positive rate, though lactulose remains widely used and is the substrate in most commercial kits.

What Is a Normal SIBO Breath Test Range?

Normal means your gas levels stay low and flat. A result is considered negative when:

• Fasting baseline hydrogen is below 20 ppm
• Hydrogen does not rise by 20 ppm or more above baseline within the first 90 minutes
• Methane stays below 10 ppm at every time point
• Hydrogen sulfide (if measured) stays below 3 ppm

These thresholds come from the 2017 North American Consensus, which involved 17 gastroenterology experts and represents the most widely cited framework in current clinical practice.

A high baseline hydrogen (above 20 ppm before you drink anything) suggests you did not prep correctly, still have bacteria producing gas from a previous meal, or have a very high baseline bacterial load. Some labs will void the test and ask you to repeat it.

Why "Normal" Is Harder to Define in Women

Women have measurably slower whole-gut transit times than men on average, a sex difference documented in a meta-analysis of 23 studies. Slower transit gives bacteria more time to ferment carbohydrates before they reach the colon, which can push gas levels upward even in women without true overgrowth. This means a borderline result (a hydrogen rise of 20-25 ppm) deserves more clinical context in a woman, not less.

Progesterone slows intestinal motility. During the luteal phase of your cycle (roughly days 15-28), progesterone peaks and transit time slows further. If you happen to take your breath test in the luteal phase, your result may read slightly higher than if you tested in the follicular phase. No major guideline has issued cycle-specific testing recommendations yet, but this is an active area of discussion in functional gastroenterology.

What Does a High SIBO Breath Test Mean?

A positive result means your small intestine has more bacteria than expected, and those bacteria are producing gas at a rate that exceeds normal colonic fermentation timing.

Hydrogen-Dominant Positive

A rapid hydrogen rise (20 ppm or more above baseline before the 90-minute mark) is the classic positive pattern. Clinically, hydrogen-dominant SIBO tends to correlate with:

• Diarrhea-predominant IBS (IBS-D)
• Bloating that worsens within 1-2 hours of eating
• Loose or urgency-driven bowel movements

A 2020 meta-analysis in Gut found that among patients with IBS, SIBO prevalence on breath testing was approximately 31%, compared with 4% in healthy controls, with hydrogen-positive results predominating in diarrhea-predominant subtypes.

Methane-Dominant Positive (Intestinal Methanogen Overgrowth)

When methane hits 10 ppm or above at any single reading, the current terminology has shifted. Experts now call this intestinal methanogen overgrowth (IMO) rather than methane-SIBO, because methanogens (M. Smithii) colonize both the small and large intestine. The Rome Foundation and the 2022 ACG Clinical Guideline on IBS acknowledge IMO as a distinct entity.

Methane-dominant results are strongly associated with:

• Constipation (Bristol stool types 1-2)
• Incomplete evacuation
• Slower whole-gut transit

Women are disproportionately affected by constipation-predominant IBS, which may partly explain why IMO is commonly encountered in female patients presenting with bloating and constipation that does not respond to standard fiber advice.

What a High Result Does Not Tell You

A positive breath test alone does not tell you why you have overgrowth. The underlying cause matters enormously for treatment success. Common drivers in women include:

• Low stomach acid (hypochlorhydria), which can occur with long-term proton pump inhibitor use or autoimmune gastritis
• Impaired migrating motor complex (MMC): The MMC is the intestinal "housekeeping wave" that sweeps bacteria forward between meals. Stress, hypothyroidism, and high progesterone states all blunt MMC activity.
• PCOS: Women with PCOS have altered gut microbiome composition. A 2021 study in Frontiers in Endocrinology found significantly higher rates of gut dysbiosis and intestinal permeability markers in women with PCOS compared to controls, though breath-test-specific SIBO prevalence data in PCOS remains limited.
• Hypothyroidism: Thyroid hormone regulates gut motility. A study in Digestive Liver Disease found SIBO prevalence of 54% in hypothyroid patients versus 5% in controls using glucose breath testing.
• Endometriosis: Endometrial lesions can cause adhesions that alter bowel anatomy and slow transit, creating conditions favorable for overgrowth.
• Post-infectious IBS: A prior bout of food poisoning or gastroenteritis can trigger SIBO via damage to intestinal nerve cells (post-infectious dysmotility).

What Does a Low or Negative SIBO Breath Test Mean?

A flat graph with no meaningful gas rise is a negative result. That is the goal. For most women, a negative test combined with persistent GI symptoms points the investigation elsewhere.

When a Negative Result Still Leaves Questions

A negative result does not rule out:

• Distal SIBO missed by glucose testing (bacteria only in the lower small intestine)
• H2S-dominant SIBO if your device only measures two gases
• Fungal overgrowth (SIFO): Candida and other fungi do not produce hydrogen or methane, so they are completely invisible on breath testing
• Large intestinal dysbiosis or colonic motility disorders
• Visceral hypersensitivity: Women with IBS often have a lower pain threshold in the gut regardless of bacterial load, which means a negative SIBO test does not invalidate your symptoms

A useful clinical framework: treat the breath test as one piece of a three-part puzzle. Gas pattern tells you what bacteria are doing. History and symptom timing tell you where to look. Underlying drivers (hormones, motility, anatomy) tell you why it keeps coming back. Many women who have been on multiple antibiotic courses without lasting relief are missing that third piece.

The "Low Flat Line" That May Not Be Negative

Some women produce very little hydrogen even with significant bacterial load, because their gut flora leans toward methane-producers or sulfur-reducers rather than hydrogen producers. If your hydrogen line stays below 5 ppm for the entire test but you have all the classic symptoms, ask your provider about tri-gas testing or alternative diagnostic approaches such as a comprehensive stool analysis.

How SIBO Breath Test Results Differ Across Life Stages

Reproductive Years (Ages 18-40)

Hormonal cycling means your gut motility fluctuates month to month. Women in their reproductive years with SIBO often notice that bloating and symptoms peak in the luteal phase, ease slightly after menstruation, and flare around ovulation. This is not random. Estrogen has a mild prokinetic effect on the gut; progesterone does the opposite. Tracking symptoms alongside your cycle for two months before testing helps your provider contextualize a borderline result.

Trying to Conceive and Fertility Treatment

SIBO has not been studied as a direct cause of infertility, but gut inflammation and intestinal permeability associated with overgrowth can affect systemic inflammation markers relevant to implantation. If you are undergoing IVF, discuss timing of any antibiotic-based SIBO treatment with your reproductive endocrinologist before starting, since rifaximin and neomycin both have pregnancy-related considerations.

Perimenopause

The perimenopausal transition brings falling estrogen and rising progesterone variability. Slower gut transit during this stage is extremely common and under-recognized. Women in perimenopause often find their previously manageable bloating becomes severe. A positive SIBO result in perimenopause may reflect the transit changes of hormonal transition rather than a new infectious process. Addressing gut motility alongside bacterial overgrowth typically produces better outcomes than antibiotics alone.

Post-Menopause

Estrogen loss after menopause reduces gut mucosal integrity and alters the microbiome composition. A 2021 review in Maturitas found that the gut microbiome of post-menopausal women shifts toward lower diversity and higher abundance of some inflammatory bacterial species. Whether this directly increases SIBO rates in post-menopausal women has not been studied in a large prospective trial, which is a genuine evidence gap worth naming.

Pregnancy and Lactation: What You Need to Know

Breath testing is not routinely recommended during pregnancy. The prep protocol (a 12-hour fast, a large bolus of fermentable sugar) carries practical risks in a pregnant woman, and gas readings are harder to interpret given the profound changes in gut motility during pregnancy.

Why Pregnancy Itself Mimics SIBO

Progesterone dominates gut physiology during pregnancy. It relaxes smooth muscle throughout the GI tract, slowing transit substantially. Bloating, constipation, and bacterial fermentation all increase as a result. A positive breath test obtained during pregnancy would be difficult to distinguish from pregnancy-normal physiology.

If you are pregnant and have symptoms that suggest SIBO, the clinical recommendation is to manage symptoms conservatively (dietary modification, safe probiotics, motility support appropriate for pregnancy) and defer formal breath testing to the postpartum period.

Postpartum and Lactation

SIBO treatment antibiotics have specific lactation profiles:

• Rifaximin (Xifaxan): Minimally absorbed systemically (<0.4% bioavailability). Limited data exist on breast milk transfer, but because systemic levels are very low, many clinicians consider it relatively safe during lactation. The FDA prescribing information does not include lactation studies, so the decision requires individualized discussion.
• Neomycin: Not recommended during lactation due to limited safety data and potential infant hearing risk if any systemic transfer occurs.
• Metronidazole (used for hydrogen sulfide patterns): Excreted in breast milk. The CDC guidelines on breastfeeding and medications note that a single high dose requires a 12-24 hour pumping pause, while multiple-dose courses require a case-by-case risk discussion.

No SIBO antibiotic has strong lactation safety data from prospective trials. Rifaximin is the most commonly used in this context given its low systemic absorption, but document this conversation with your provider and, where possible, consult a lactation pharmacist.

How to Lower Your SIBO Breath Test Result (What Treatment Looks Like)

A high result prompts treatment aimed at reducing bacterial load and restoring motility. The treatment depends on your gas pattern.

Hydrogen-Dominant Treatment

The ACG Clinical Guideline on IBS (2021) gives a conditional recommendation for rifaximin 550 mg three times daily for 14 days in non-constipated IBS, which overlaps substantially with hydrogen-dominant SIBO management. Rifaximin is a gut-targeted antibiotic with minimal systemic absorption.

Alternative or adjunct approaches include:

• Elemental diet for 2-3 weeks: A 2004 study in Digestive Diseases and Sciences found an elemental formula diet normalized breath tests in 80% of SIBO patients, comparable to antibiotic response rates.
• Herbal antimicrobials: A small randomized trial found herbal protocols (including berberine and oregano oil combinations) showed similar breath-test normalization rates to rifaximin in a subset of patients, though trial quality was limited.
• Prokinetic therapy: Addressing slow transit (low-dose naltrexone, ginger, 5-HTP) alongside antibiotics reduces SIBO recurrence rates in observational data.

Methane-Dominant (IMO) Treatment

Methanogens are more resistant than hydrogen-producing bacteria. The combination of rifaximin 550 mg three times daily plus neomycin 500 mg twice daily for 14 days is the most evidence-backed protocol for IMO. A randomized controlled trial by Pimentel et al. showed that dual-antibiotic therapy achieved significantly better methane normalization than rifaximin alone (87% vs. 34% in methane producers).

How Soon Should You Re-Test?

Most gastroenterologists recommend repeating the breath test no sooner than 4 weeks after completing antibiotics, and ideally at 6-8 weeks, to allow the bacterial field to stabilize. Testing too early gives a falsely negative or falsely positive result depending on antibiotic residual effect and repopulation speed.

Who This Lab Is Right For (and Who Should Wait)

You are a good candidate for SIBO breath testing if you have:

• Bloating that consistently worsens 30-90 minutes after eating
• IBS that has not responded to standard dietary changes
• Unexplained diarrhea or constipation with food-related patterns
• A history of prior GI infection followed by new gut symptoms
• Diagnosed hypothyroidism with persistent GI symptoms despite controlled TSH
• PCOS with significant bloating, especially if also experiencing blood sugar dysregulation

You may want to wait, or interpret results with extra caution, if you have:

• Just finished antibiotics (within 4 weeks)
• Are currently pregnant
• Have a known motility disorder such as gastroparesis (results are harder to interpret)
• Are in the luteal phase and have a borderline result (consider retesting in the follicular phase)

Interpreting Your Results: A Practical Summary Table

| Gas | Baseline | Response | Interpretation | |-----|----------|----------|---------------| | Hydrogen | <20 ppm | Rises ≥20 ppm above baseline by 90 min | Positive for SIBO (hydrogen-type) | | Hydrogen | <20 ppm | No significant rise | Negative (for proximal/mid SIBO) | | Methane | Any | ≥10 ppm at any time point | Positive for IMO | | Hydrogen sulfide | <3 ppm | ≥3 ppm | Positive for H2S SIBO (tri-gas device required) | | Hydrogen | ≥20 ppm at baseline | N/A | Invalid test; repeat after proper prep |

"A positive breath test is a starting point, not a destination. The goal is to understand why this patient's small intestine is allowing bacteria to accumulate, not simply to eradicate them once with antibiotics," according to expert consensus commentary in the North American Consensus guidelines on breath testing.

Questions to Ask Your Provider After Seeing Your Results

Even with a clear positive or negative result, these questions move your care forward:

1. Which substrate was used, and could distal SIBO have been missed?
2. Was hydrogen sulfide measured, or only a two-gas panel?
3. What is my most likely underlying driver given my hormone and thyroid history?
4. If I am in perimenopause, should we address motility before antibiotics?
5. What is the plan if my symptoms return within six months of treatment?

A conversation that answers those five questions will generate more usable next steps than a result number alone.